• Patents


Useof specific BAG3 nucleotide and protein sequences in research, diagnostics andtherapy for cell death-involving diseases:

1)WO/2003/055908 – PCT/EP2002/014802 (BAG3 nucleotide and protein sequences tobe used in research, diagnostics and therapy for cell death-involving diseases);granted in: AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT,LT, LU, LV, MC, MK, NL, PY, RO, SE, SI, SK, TR, US, CA.

Useof BAG3 as biomarker

2)WO 2011/067377 A1 (Biochemical serum marker), filed 12/2010. Granted in:AT, BE, DK,  FI, FR,  DE, IE, IT, PT, RO, ES, SE, CH, TR, UK,China, US, Japan, Hong Kong.

3)PCT/EP 2013/061976 (Biochemical serum and tissue markers), filed06/2012.

4)PCT/EP2013/061971 (BAG3 RNA for use as biochemical markers), filed  06/2012.

Useof BAG3 and its receptors as therapeutic targets:

5)PCT/IB2014/059416  (Anti-bag3 antibodies for therapeutic use),03/2014

6)PCT/IB2014/059416 (Bag3 receptor binding molecules for use as amedicament), filed 07/2014